How We Broke a Global Life Sciences CMO Into the U.S. Market and Grew Traffic 263%

A global contract manufacturing organization (CMO) in life sciences had strong operations in Europe and Asia, serving major pharma and biotech clients around the world. However, they had almost no online presence in the U.S. They did not appear in search results, had little organic traffic, and their website did not build trust with American buyers. Our content and SEO strategy turned this around, increasing organic traffic by 263% in less than a year.

Why Did a Globally Recognized CMO Have No U.S. Search Presence?

This problem is more common than many people think. Life sciences companies with strong international reputations often believe their brand will be recognized when they enter new online markets. But this is not the case, especially in the U.S., where search habits, regulations, and buyer expectations are very specific.

The client’s website was designed for a broad, international audience. It used general language about their services but did not address the specific problems U.S.-based biotech and pharmaceutical companies wanted to solve. There were no pages focused on early-stage drug development outsourcing, no content about FDA manufacturing concerns, and no language that matched how American buyers discuss contract manufacturing.

Search engines like Google decide what a website is an authority on by looking at the topics and terms it covers regularly. This client had strong authority in other markets, but in the U.S., their search presence was almost nonexistent. We had to start from the beginning.

“Global brand recognition does not automatically translate into search authority in a new market. U.S. buyers search with very specific language around FDA expectations, GMP standards, and development-stage fit. If your content does not reflect that language, you simply will not appear when they search.” – Strategy Team, Emulent Marketing.

How Did We Map the U.S. Buyer Before Writing a Single Word?

Before making any changes to the website, we first identified who the real U.S. buyers were and what they searched for. In life sciences CMO selection, buyers are usually VP-level or higher at biotech startups, mid-size pharma companies, and large pharmaceutical organizations. Each group has its own questions, timelines, and priorities.

We identified three core buyer segments and built content targets around each:

The three buyer segments we mapped content around:

• Early-stage biotech companies want a CMO partner who can manage small-batch manufacturing and help with IND filing. They look for partners with flexibility, a strong regulatory track record, and proven feasibility.
• Mid-size pharmaceutical companies are focused on scaling an existing molecule. They look for capacity, the right technology platform, strong quality systems, and reliable supply chains.
• Large pharma procurement teams use structured vendor evaluations for established products. They care most about detailed facility audit results, a strong regulatory inspection history, and advanced analytical capabilities that meet strict procurement standards.

Next, we found the real search terms and topics each group used by studying top competitor pages, industry publications, and FDA resources. We created a full topic map before writing, so every piece of content had a clear audience, a specific search intent, and links to related content on the site.

What Did the Content Strategy Actually Look Like in Practice?

Our content strategy focused on building authority on key topics, not just targeting keywords. Search engines reward sites that cover a subject thoroughly, not those with just one keyword-heavy page. For a life sciences CMO, this meant covering everything American biotech and pharma buyers need to know when choosing a manufacturing partner.

We organized the content into three layers. The first layer was high-level service pages, each rewritten to speak directly to U.S. buyer concerns. These pages described the client’s main manufacturing capabilities using terms American buyers know, such as GMP-compliant manufacturing, FDA inspection readiness, support for IND and commercial stages, and U.S.-based quality oversight.

The second layer included detailed topic pages focused on specific problems. Pages such as “How to Select a CMO for Early-Stage Drug Development” or “What to Ask a Contract Manufacturer About FDA Compliance” gave buyers useful information and highlighted the client’s strengths. These pages drove most of the organic traffic growth because they answered the real questions buyers search for.

The third layer was a collection of shorter, question-focused pieces aimed at very specific searches. These articles captured long-tail traffic from buyers at different research stages and brought them to the main site.

“The companies that win on organic search in life sciences are not the ones with the most content. They are the ones whose content maps precisely to how buyers think through a decision. That means covering not just what you do, but why it matters at each stage of drug development.” – Strategy Team, Emulent Marketing.

How Did We Build Search Authority in a Highly Regulated, Technical Field?

Writing about life sciences manufacturing for a U.S. audience is different from writing general marketing copy. The audience is technical, the regulations are specific, and buyers quickly dismiss content that seems shallow. We needed to build real authority, not just add more words.

First, we worked with the client’s internal experts to gather real knowledge. By interviewing them, we got accurate, specific details about their processes, quality systems, and technical abilities. This level of detail is what makes content stand out and rank well.

Second, we made sure the site linked related topics in a clear and logical way. For example, when a page about small-batch manufacturing mentioned FDA process validation, it linked to a separate page with full details. This structure shows search engines that the site covers topics in depth, not just at the surface.

Third, we reached out to established pharmaceutical and biotech industry publications to get references back to the site. Links from trusted industry sources are some of the strongest signals Google uses to rank sites. We created a targeted outreach list of U.S.-based life sciences publications and secured placements that linked to important pages.

The key technical improvements we made alongside the content work:

• Page structure and header hierarchy: We restructured every key page so the main topic was in the H1, supporting topics in H2s, and specific details in H3s. This matches how search engines read and organize content.
• Schema markup for organization and services: We added structured data to the site so search engines could correctly identify the company as a life sciences manufacturing organization with specific service types.
• Page speed and mobile performance: The original site loaded slowly on mobile devices, which hurt rankings everywhere. We found and fixed the main problems to improve performance scores to a competitive level.
• Clear definitions for key terms: We defined industry terms the first time they appeared in every piece of content. This made the content easier to read for less-technical buyers and helped Google understand the page better.

“In a technical B2B field like life sciences, you cannot fake authority. Buyers know the difference between content written by someone who understands drug development and content written by someone who Googled it. The best content strategy pulls real expertise out of the client and packages it in a way buyers can actually find and use.” – Strategy Team, Emulent Marketing.

What Results Did We See, and How Long Did It Take?

Organic traffic growth in a competitive B2B market takes time. We spent the first two months on strategy, restructuring the site, and creating content. By the third month, we began publishing the first set of new and updated content.

By month six, the site had more than doubled its year-over-year traffic. New service pages ranked on the first page of Google for several valuable U.S.-specific search terms. Topic pages for early-stage biotech buyers performed especially well because this group was actively searching and few competitors had answered their questions in detail.

By month eleven, organic traffic had increased by 263% year over year. Qualified leads from the website grew at the same rate. The client’s U.S. sales team said that new inquiries were coming from prospects who had read specific content and already understood the client’s capabilities. This made sales conversations shorter and improved conversion rates.

The traffic growth was broad and not tied to just one high-volume keyword. We built rankings for dozens of specific, mid- to long-tail terms that together created a large and steadily growing traffic base. This made the growth more stable and less vulnerable to changes in search algorithms.

This approach highlights three key lessons for life sciences companies entering the U.S. market:

1. First, building a U.S.-specific search authority requires more than international reputation.
2. Second, mapping buyer needs and search intent is essential for content impact.
3. Third, comprehensive, authoritative content that reflects market language drives visibility and qualified leads.

These steps were essential to our client’s success and can help others who want to reach U.S. life sciences buyers.

The main lesson from this project is that entering the U.S. market online means thinking like a U.S. buyer, not just translating your global messaging. American biotech and pharma buyers use very specific language and filter options quickly. They have regulatory and quality concerns unique to the FDA system. If your content does not reflect this, it will not rank—and even if it does, it will not convert.

Second, authority in technical fields comes from depth, not quantity. A few well-researched, well-structured pages that truly help buyers make decisions will always outperform a large collection of thin, general content. Search engines are now very good at spotting the difference.

Third, SEO in life sciences is a medium- to long-term investment. The results in this case study came from steady, structured work over almost a year. Companies hoping for big organic growth in sixty days will be disappointed, no matter what approach they use. The payoff is real, but it takes patience and commitment.

Ready to Build a Search Presence in the U.S. Life Sciences Market?

Growing organic traffic in a technical, regulated field requires a clear plan and the ability to execute across content, technical SEO, and authority-building simultaneously. The Emulent Marketing team works with life sciences and B2B companies to build search presence that drives qualified traffic and real business results.

If your company is looking to grow its search presence or enter a new market online, contact the Emulent team to discuss what an SEO strategy tailored to your market could look like.